Browsing Tag
European Union
123 posts
Alexion’s Soliris approved for paediatric myasthenia gravis treatment in EU
Soliris (eculizumab), the first and only targeted therapy approved for the treatment of paediatric patients with refractory generalised…
July 29, 2023
Gilead’s Trodelvy gains EC approval as new hope for metastatic breast cancer patients
In a significant advancement for cancer treatment, the European Commission (EC) has approved Gilead Sciences’ Trodelvy (sacituzumab govitecan)…
July 27, 2023
CHMP endorses Merck’s gefapixant for EU approval for chronic cough treatment
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval for gefapixant,…
July 22, 2023
European Parliament condemns Indian govt over Manipur violence during Modi’s France visit
The European Parliament condemned the Indian government for the violence in Manipur and called on it to protect…
July 13, 2023
FREYR Battery’s Giga Arctic project receives major boost with €100m EU grant
FREYR Battery, a global front-runner in next-generation battery cell production technology, has disclosed the receipt of a €100…
July 13, 2023
Erdogan’s shocker: Sweden’s NATO dreams at mercy of Turkey’s EU ambitions
In an intriguing turn of events, Turkish President Recep Tayyip Erdogan declared that he would only support Sweden’s…
July 10, 2023
ALX Oncology gets EC’s orphan drug status for evorpacept in gastric cancer
ALX Oncology Holdings, an Australian immuno-oncology company focusing on CD47 checkpoint pathway blocking therapies, declared a significant milestone…
June 27, 2023
Incyte bags Opzelura EC approval for treatment of non-segmental vitiligo
Incyte has secured marketing authorization for Opzelura (ruxolitinib) cream 15mg/g from the European Commission (EC) for non-segmental vitiligo…
April 23, 2023
Bristol Myers Squibb gets Reblozyl EC approval for anemia associated with NTD beta thalassemia
Bristol Myers Squibb (BMY) has secured full marketing authorization for Reblozyl (luspatercept) from the European Commission (EC) for…
March 4, 2023
Sanofi, Regeneron get Dupixent EC approval for eosinophilic esophagitis
French pharmaceutical company Sanofi and Regeneron, an American biotechnology company, have received the approval of the European Commission…
February 1, 2023